Juan S Uribe1, Armen R Deukmedjian. 1. Department of Neurosurgery and Brain Repair, University of South Florida, 2 Tampa General Circle, 7th Floor, Tampa, FL, 33606, USA, juansuribe@gmail.com.
Abstract
PURPOSE: Minimally invasive lateral interbody fusion (MIS-LIF) has become a popular less invasive treatment option for degenerative spinal disease, deformity, and trauma. While MIS-LIF offers several advantages over traditional anterior and posterior approaches, the procedure is not without risk. The purpose of this study was to evaluate the incidence of visceral, vascular, and wound complications following MIS-LIF performed by experienced surgeons. METHODS: A survey was conducted by experienced (more than 100 case experience) MIS-LIF surgeons active in the society of lateral access surgery (SOLAS) to collect data on wound infections and visceral and vascular injuries. Of 77 spine surgeons surveyed, 40 (52 %) responded, including 25 (63 %) orthopedic surgeons and 15 (38 %) neurosurgeons, with 20 % practicing at an academic institution and 80 % in community practice. RESULTS: Between 2003 and 2013, 13,004 patients were treated with MIS-LIF by the 40 surgeons who responded to the survey. Of those patients, 0.08 % experienced a visceral complication (bowel injury), 0.10 % experienced a vascular injury, 0.27 % experienced a superficial wound infection, and 0.14 % experienced a deep wound infection. CONCLUSION: The incidence of surgical site infections and vascular and visceral complications following MIS-LIF in this large series was low and compared favorably with rates for alternative interbody fusion approaches. Although technically demanding, MIS-LIF is a reproducible approach for interbody fusion with a low risk of vascular and visceral complications and infections.
PURPOSE: Minimally invasive lateral interbody fusion (MIS-LIF) has become a popular less invasive treatment option for degenerative spinal disease, deformity, and trauma. While MIS-LIF offers several advantages over traditional anterior and posterior approaches, the procedure is not without risk. The purpose of this study was to evaluate the incidence of visceral, vascular, and wound complications following MIS-LIF performed by experienced surgeons. METHODS: A survey was conducted by experienced (more than 100 case experience) MIS-LIF surgeons active in the society of lateral access surgery (SOLAS) to collect data on wound infections and visceral and vascular injuries. Of 77 spine surgeons surveyed, 40 (52 %) responded, including 25 (63 %) orthopedic surgeons and 15 (38 %) neurosurgeons, with 20 % practicing at an academic institution and 80 % in community practice. RESULTS: Between 2003 and 2013, 13,004 patients were treated with MIS-LIF by the 40 surgeons who responded to the survey. Of those patients, 0.08 % experienced a visceral complication (bowel injury), 0.10 % experienced a vascular injury, 0.27 % experienced a superficial wound infection, and 0.14 % experienced a deep wound infection. CONCLUSION: The incidence of surgical site infections and vascular and visceral complications following MIS-LIF in this large series was low and compared favorably with rates for alternative interbody fusion approaches. Although technically demanding, MIS-LIF is a reproducible approach for interbody fusion with a low risk of vascular and visceral complications and infections.
Authors: Allen L Carl; John Kostuik; Cameron B Huckell; Jean-Jacques Abitbol; Morio Matsumoto; Ann Sieber Journal: Spine J Date: 2003 Sep-Oct Impact factor: 4.166
Authors: Vivek A Mehta; Matthew J McGirt; Giannina L Garcés Ambrossi; Scott L Parker; Daniel M Sciubba; Ali Bydon; Jean-Paul Wolinsky; Ziya L Gokaslan; Timothy F Witham Journal: Neurol Res Date: 2010-06-11 Impact factor: 2.448
Authors: D H Szolar; K W Preidler; H Steiner; T Riepl; G Flaschka; M Stiskal; S Moelleken; D Norman Journal: Neuroradiology Date: 1996-08 Impact factor: 2.804
Authors: Benjamin K Potter; Brett A Freedman; Eric G Verwiebe; Jordan M Hall; David W Polly; Timothy R Kuklo Journal: J Spinal Disord Tech Date: 2005-08
Authors: Nasir A Quraishi; M Konig; S J Booker; M Shafafy; B M Boszczyk; M P Grevitt; H Mehdian; J K Webb Journal: Eur Spine J Date: 2012-12-19 Impact factor: 3.134
Authors: Salvador A Brau; Rick B Delamarter; Michael L Schiffman; Lytton A Williams; Robert G Watkins Journal: Spine J Date: 2004 Jul-Aug Impact factor: 4.166
Authors: Gary A Fantini; Ioannis P Pappou; Federico P Girardi; Harvinder S Sandhu; Frank P Cammisa Journal: Spine (Phila Pa 1976) Date: 2007-11-15 Impact factor: 3.468
Authors: Ankur S Narain; Fady Y Hijji; Jonathan S Markowitz; Krishna T Kudaravalli; Kelly H Yom; Kern Singh Journal: Curr Rev Musculoskelet Med Date: 2017-12
Authors: Michael M Safaee; Devin Zarkowsky; Charles M Eichler; Murat Pekmezci; Aaron J Clark Journal: Eur Spine J Date: 2018-05-07 Impact factor: 3.134